SCHMERTZLER MICHAEL

Average Profitability
49.41%
Insider Buys Quantity
6
Insider Buys Sum
$17.21M
Insider Sells Quantity
10
Insider Sells Sum
$6.41M

Insider Activity of SCHMERTZLER MICHAEL

According to the SEC Form 4 filings, SCHMERTZLER MICHAEL, being in a position of

  1. director at PTC Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 1500 shares for $41,715,
    over all time since 2013-03-07, has bought 911841 share for $11.21M, and sold 2500 shares for $86,575.

The largest purchase of all time was on 2013-06-25 and amounted to 533333 shares of PTC Therapeutics, Inc. for $8M.

The largest sale of all time was on 2010-05-18 and amounted to 829176 shares of Cytokinetics, Incorporated for $2.49M.

Biography of SCHMERTZLER MICHAEL

No biography is available at this moment.

2024-01-08SalePTC Therapeutics, Inc.
PTCT
director
1,500
0.0019%
$27.81$41,715+7.94%
2023-06-07SalePTC Therapeutics, Inc.
PTCT
director
1,000
0.0014%
$44.86$44,860-34.47%
2020-03-16PurchasePTC Therapeutics, Inc.
PTCT
director
20,000
0.0322%
$32.48$649,692+60.5%
2019-01-25PurchasePTC Therapeutics, Inc.
PTCT
director
66,225
0.1217%
$30.20$2M+38.99%
2014-02-19PurchasePTC Therapeutics, Inc.
PTCT
23,000
0.0806%
$24.50$563,500+12.68%
2013-06-25PurchasePTC Therapeutics, Inc.
PTCT
533,333
1.9161%
$15.00$8M+8.52%
2013-03-07PurchasePTC Therapeutics, Inc.
PTCT
269,283
–
$0$0
2010-06-03SaleCytokinetics, Incorporated
CYTK
director
10,764
0.0169%
$3.00$32,292-27.76%
2010-05-27SaleCytokinetics, Incorporated
CYTK
director
115,216
0.1805%
$3.00$345,648-27.33%
2010-05-19SaleCytokinetics, Incorporated
CYTK
director
32,478
0.0516%
$3.00$97,434-25.34%
2010-05-18SaleCytokinetics, Incorporated
CYTK
director
829,176
1.3037%
$3.00$2.49M-25.75%
2010-05-12SaleCytokinetics, Incorporated
CYTK
director
165,476
0.2576%
$3.00$496,428-26.16%
2010-05-11SaleCytokinetics, Incorporated
CYTK
director
73,000
0.1159%
$3.00$219,000-24.66%
2010-05-06SaleCytokinetics, Incorporated
CYTK
director
66,892
0.1069%
$3.03$202,683-24.92%
2010-05-05SaleCytokinetics, Incorporated
CYTK
director
804,200
1.277%
$3.04$2.44M-25.33%
2009-05-21PurchaseCytokinetics, Incorporated
CYTK
director
3.05M
5.7448%
$1.97$6M+68.65%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.